Skip to Main Content

Current Clinical Trials

Breast

Disease Site Title Status
Breast

Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Breast

A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Breast

Aspirin in Preventing Recurrence of Cancer in Patients with Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Breast

Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant (BYLieve)

Principal Investigator: Ike Onwere, MD

Click here for more information on this trial.
Breast

To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Breast

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Principal Investigator: Michael Wahl, MD

Click here for more information on this trial.


Lung

Disease Site Title Status
Lung

Genetic Testing in Screening Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Crizotinib in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Nivolumab After Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer (ANVIL)

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Lung

Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Principal Investigator: Michael Wahl, MD

Click here for more information on this trial.
Lung

Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.


Other

Disease Site Title Status
Prostate Registry
(Not a treatment trial)
Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) (TRUMPET)

Principal Investigator: David Hufnagel, DO
Click here for more information on this trial.
Advanced Cancers

NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma

Principal Investigator: Wei Bai, MD

Click here for more information on this trial.
Colon

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Bladder

Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer

Principal Investigator: David Hufnagel, DO

Click here for more information on this trial.
Myelofibrosis and Essential Thrombocythemia

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Principal Investigator: Ike Onwere, MD

Click here for more information on this trial.

To learn more about cancer clinical trials available, visit clinicaltrials.gov.

 

Disease Site Title Status
Patients with certain kinds of Pacemakers MultiPoint Pacing™ Post Market Study (MPP-PMS)

Click here for more information on this trial.

Patients with Heart Failure, but Preserved Ejection Fraction

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients (PARALLAX)

 

Principal Investigator: Sridhar Vijayasekaran, MD

Click here for more information on this trial.
Patients with a New Index Myocardial Infarction (MI)

Prospective ARNI vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)

 

Principal Investigator: Edward Toggart, MD

Click here for more information on this trial.
Device Study Looking for Patients Who Have a Current Generation Pacemaker Device Who Are in Need of an MRI

SJM MRI Diagnostic Imaging Registry (IDE)

 

Principal Investigator: Jeff Hsing, MD

Click here for more information on this trial.
PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Loperamide
PUMA-NER-6201: A Study Looking at the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and L

 

Disease Site Title Status
Invasive Fungal Infections Registry (Not a treatment trial)

Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles

Principal Investigator: Sugat Patel, MD

Click here to learn more about this trial.

 

Condition Title Status
Insulin Sensitivity, Obesity and Sedentary Lifestyle

Exercise and Insulin Signaling in Human Skeletal Muscle

Samaritan Health Services Principal Investigators: Craig Graham, MD, Nicholas Phillips, MD, and Josh Lenhof, DO


Oregon State University Principal Investigators: Sean Newsom, PhD, and Matthew Robinson, PhD

Click here for more information on this trial or review an informational flyer.
Cardiac registry for student athletes Cardiovascular Screening in the Pac-12 Conference: Establishing Best Practices Click here for more information on this trial.

For more information about clinical research at Samaritan, call 541-768-4352.